chemical:semaglutide Kidney injuries on Ozempic Recent reports of kidney injuries have caused a change in requirements for GLP1 labeling. We dive into the actual risk and what you can do about it.
category:risks A new risk? Macular Degeneration We explore the new GLP1 risk factor for macular degeneration (nAMD) that has been reported in a study published to JAMA.
category:news A new risk: Kidney Cancer New study suggests link between GLP1 Receptor Agonists (Ozempic, Mounjaro, etc) and kidney cancer.
category:side-effects Pancreatitis and Gallstones after massive weight loss We look into pancreatitis and gallstones issues that caused one death and more hospitalizations, caused at least in part by GLP1s
category:side-effects Anxiety and suicidal thoughts after stopping GLP1s? Reports of anxiety and suicidal reports have been reported for people after *stopping* use of GLP1s. We dig in, and weight the FDA's comments.
